Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ronrydellon Mar 05, 2013 1:28pm
186 Views
Post# 21080893

RE: RE: RE: RE: RE: RE: RE: "Gang of three" leavin

RE: RE: RE: RE: RE: RE: RE: "Gang of three" leavin

Again..SF you're doing a lot of posting on this..now it would be most appropriate to call Sarah as she is offering to clarify. If she's inviting me to call, she'll also talk to you as we are both ordinary shareholders with "skin in the game" Your conversation will be much more meaningful then mine. I'm not that knowledgeable in the issues that you are raising except I see an ABRUPT slowing down in share price and volume.

This whole matter is obviously giving people pause with the potential of mega millions in Market Cap on the block. It's in everyone's best interest, shareholders, prospective consumers and management to hear the issues you bring up clarified without the usual disclaimer "we only can refer you to publically discussed NR's etc"

Please respond to this..Thx.

Bullboard Posts